Company Quick10K Filing
KBL Merger IV
10-Q 2020-03-31 Filed 2020-05-22
10-K 2019-12-31 Filed 2020-04-07
8-K 2020-06-02
8-K 2020-04-08
8-K 2020-01-29

KBL Merger IV Financials

KBLM Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2018-12-312019-03-312019-06-302019-09-30
Cash271135110836
Accounts Receivable
Inventory
PP&E
Assets118,43766,47150,23751,573
Accounts Payable
Long-Term Debt196226256
Liabilities4,5715,2035,4566,813
Stockholders' Equity5,0005,0005,0005,000
Income Statement ($'000)2018-12-312019-03-312019-06-302019-09-30
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A265296226
Tax1087051
Net Income232-11-22
Cash Flow ($'000)2018-12-312019-03-312019-06-302019-09-30
Cash Operating-307-637-216
Cash Investing53,00516,654-388
Cash Financing-52,834-16,0421,330